Loading…
Prostate Cancer Misdiagnosis Elimination Act of 2017
Legislative Progress
Momentum (last 30 days)
0
score
0 actions · 0 new cosponsors · 0 votes
Speed vs cohort
0pct
0d open
vs 3,805 other S bills in the 115th — cohort avg 41d
Prostate Cancer Misdiagnosis Elimination Act of 2017 This bill provides for Medicare coverage of a DNA Specimen Provenance Assay clinical diagnostic laboratory test following a positive prostate cancer biopsy.
These links require the bill number to appear in the filing's source-reported specific issue text. Client expenses and lobbying-firm income are separate disclosure fields.
Filing registrants (2)
2018 · fourth_quarter · Medicare/Medicaid
H.R. 2557/ S. 2067 - Prostate Cancer Misdiagnosis Elimination Act of 2017. H.R. 6886 - HEARTS Act of 2018.
Client expense: Not reported · Firm income: $20,000
Read twice and referred to the Committee on Finance.
Introduced in Senate
Bills with similar content found using semantic analysis.
Sources: Congress.gov
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2018 · fourth_quarter · Medicare/Medicaid
Support for H.R. 2557 / S. 2067 - Prostate Cancer Misdiagnosis Elimination Act of 2017. Support for H.R. 6886 - HEARTS Act of 2018.
Client expense: Not reported · Firm income: $20,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2018 · third_quarter · Medicare/Medicaid
H.R. 2557/ S. 2067 - Prostate Cancer Misdiagnosis Elimination Act of 2017. H.R. 6886 - HEARTS Act of 2018.
Client expense: Not reported · Firm income: $10,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2018 · third_quarter · Medicare/Medicaid
Support for H.R. 2557 / S. 2067 - Prostate Cancer Misdiagnosis Elimination Act of 2017. Support for H.R. 6886 - HEARTS Act of 2018.
Client expense: Not reported · Firm income: $20,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2018 · third_quarter · Health Issues
Legislation affecting medical diagnostics and prostate cancer. H.R. 2557/S. 2067 - Prostate Cancer Misdiagnosis Elimination Act of 2017; and H.R. 6886 - HEARTS Act of 2018.
Client expense: Not reported · Firm income: Not reported
2018 · second_quarter · Medicare/Medicaid
Support for H.R. 2557 / S. 2067 - Prostate Cancer Misdiagnosis Elimination Act of 2017.
Client expense: Not reported · Firm income: $20,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2018 · first_quarter · Medicare/Medicaid
Support for H.R. 2557 / S. 2067 - Prostate Cancer Misdiagnosis Elimination Act of 2017. Support for Medicare coverage of prostate cancer diagnostic test in H.R. 1892 - Bipartisan Budget Act.
Client expense: Not reported · Firm income: $20,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2017 · fourth_quarter · Medicare/Medicaid
Medicare coverage of diagnostic test. Support for H.R. 2557 / S. 2067 - Prostate Cancer Misdiagnosis Elimination Act of 2017.
Client expense: Not reported · Firm income: $20,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE